Home / Inspections / 1227222

FDA Inspection 1227222 — Carter BloodCare

Carter BloodCare — FEI 3003830999

The FDA completed an inspection of Carter BloodCare on January 11, 2024 in Woodway, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 11, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Woodway, TX (United States)

Facility

Other inspections at this facility

  • 1088131 (NAI Fri Apr 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1029042 (NAI Wed Aug 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 871589 (VAI Mon Mar 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 775769 (NAI Thu Apr 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 620063 (VAI Thu Oct 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources